{
  "created_at": "Fri Nov 05 12:46:26 +0000 2021",
  "id_str": "1456346534090612743",
  "full_text": "Molnupiravir has been approved by Britain’s national medicines regulatory agency—the first in the world to do so\nhttps://t.co/ke8BBaVtrB",
  "display_text_range": [
    0,
    136
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/ke8BBaVtrB",
        "expanded_url": "https://econ.st/3k9sB5M",
        "display_url": "econ.st/3k9sB5M",
        "indices": [
          113,
          136
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 33,
  "favorite_count": 85,
  "possibly_sensitive": false,
  "original_created_at": "Thu Nov 04 19:44:05 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "モルヌピラビルが英国の医薬品規制当局から世界で初めて承認されたことについて\nhttps://t.co/ke8BBaVtrB"
    },
    {
      "locale": "zh",
      "full_text": "莫努匹拉韦已被英国国家药品监管机构批准--这是世界上第一个被批准的药物。\nhttps://t.co/ke8BBaVtrB"
    },
    {
      "locale": "zh-Hant",
      "full_text": "莫努匹拉韋已被英國國家藥品監管機構批准--這是世界上第一個被批准的藥物。\nhttps://t.co/ke8BBaVtrB"
    }
  ]
}